---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-008571"
form_type: "8-K"
ticker: "XLO"
cik: "0001840233"
company_name: "Xilio Therapeutics, Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T11:11:10.799581+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Xilio stockholders elect Class I directors, approve 3x share increase and officer exculpation

## Summary
- René Russo (32.5M), Sara Bonstein (32.4M), James Shannon (31.0M) elected Class I directors.
- Share increase amendment approved: 38.8M for (95.1%), increasing authorized common from 200M to 600M shares; filed June 10.
- Officer exculpation amendment approved: 32.3M for (99.3%); filed June 10.
- Ernst & Young ratified as auditor for FY2025: 40.7M for (99.7%).

## SEC filing metadata
- accession: 0001558370-25-008571
- form_type: 8-K
- ticker: XLO
- cik: 0001840233
- company_name: Xilio Therapeutics, Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840233/000155837025008571/0001558370-25-008571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840233/000155837025008571/xlo-20250610x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-008571
- JSON: https://secwatch.observer/filing/0001558370-25-008571.json
- Plain text: https://secwatch.observer/filing/0001558370-25-008571.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.